D

Domesco Medical Import Export Joint Stock Corp
VN:DMC

Watchlist Manager
Domesco Medical Import Export Joint Stock Corp
VN:DMC
Watchlist
Price: 67 300 VND -0.88%
Market Cap: 2.3T VND
Have any thoughts about
Domesco Medical Import Export Joint Stock Corp?
Write Note

Relative Value

The Relative Value of one DMC stock under the Base Case scenario is 53 011.13 VND. Compared to the current market price of 67 300 VND, Domesco Medical Import Export Joint Stock Corp is Overvalued by 21%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

DMC Relative Value
Base Case
53 011.13 VND
Overvaluation 21%
Relative Value
Price
D
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
20
vs Industry
64
Median 3Y
1.1
Median 5Y
1.1
Industry
2.5
vs History
7
vs Industry
30
Median 3Y
12.1
Median 5Y
10
Industry
21.8
vs History
vs Industry
28
Median 3Y
10.1
Median 5Y
12.2
Industry
16.1
vs History
vs Industry
19
Median 3Y
13
Median 5Y
17.8
Industry
23.8
vs History
17
vs Industry
49
Median 3Y
1.3
Median 5Y
1.3
Industry
2.1
vs History
25
vs Industry
72
Median 3Y
0.9
Median 5Y
0.9
Industry
2.7
vs History
12
vs Industry
46
Median 3Y
3.5
Median 5Y
3.2
Industry
5.2
vs History
4
vs Industry
39
Median 3Y
6.7
Median 5Y
6.1
Industry
13.5
vs History
6
vs Industry
39
Median 3Y
7.4
Median 5Y
7
Industry
16.8
vs History
vs Industry
35
Median 3Y
8.2
Median 5Y
8.7
Industry
15.2
vs History
vs Industry
28
Median 3Y
8.5
Median 5Y
9.4
Industry
19.3
vs History
20
vs Industry
41
Median 3Y
1.3
Median 5Y
1.3
Industry
1.9

Multiples Across Competitors

DMC Competitors Multiples
Domesco Medical Import Export Joint Stock Corp Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
VN
Domesco Medical Import Export Joint Stock Corp
VN:DMC
2.4T VND 1.3 15 8.9 9.7
JP
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
776 550.9T JPY 4 211 733 -5 347 888.9 -5 459 134.4 -5 046 864.6
US
Eli Lilly and Co
NYSE:LLY
755.8B USD 18.5 90.3 48.5 54.1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
DK
Novo Nordisk A/S
CSE:NOVO B
2.7T DKK 10.2 29 20.2 23
US
Johnson & Johnson
NYSE:JNJ
351.1B USD 4 23.9 11.6 15.1
US
Merck & Co Inc
NYSE:MRK
251.8B USD 4 20.7 10.5 12.5
CH
Roche Holding AG
SIX:ROG
200.1B CHF 3.4 17.4 9.8 11.6
UK
AstraZeneca PLC
LSE:AZN
161.8B GBP 4.1 31.6 169.4 253.9
CH
Novartis AG
SIX:NOVN
171.5B CHF 3.8 10.8 9.4 13.1
US
Pfizer Inc
NYSE:PFE
151.5B USD 2.5 35.6 10.6 16
P/E Multiple
Earnings Growth P/E to Growth
VN
D
Domesco Medical Import Export Joint Stock Corp
VN:DMC
Average P/E: 30.5
15
N/A N/A
JP
N
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Negative Multiple: -5 347 888.9 N/A N/A
US
Eli Lilly and Co
NYSE:LLY
90.3
446%
0.2
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A N/A
DK
Novo Nordisk A/S
CSE:NOVO B
29
86%
0.3
US
Johnson & Johnson
NYSE:JNJ
23.9
-23%
N/A
US
Merck & Co Inc
NYSE:MRK
20.7
7 300%
0
CH
Roche Holding AG
SIX:ROG
17.4
54%
0.3
UK
AstraZeneca PLC
LSE:AZN
31.6
177%
0.2
CH
Novartis AG
SIX:NOVN
10.8
31%
0.3
US
Pfizer Inc
NYSE:PFE
35.6
719%
0
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
VN
D
Domesco Medical Import Export Joint Stock Corp
VN:DMC
Average EV/EBITDA: 414.5
8.9
N/A N/A
JP
N
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Negative Multiple: -5 459 134.4 N/A N/A
US
Eli Lilly and Co
NYSE:LLY
48.5
195%
0.2
UK
Dechra Pharmaceuticals PLC
LSE:DPH
3 846.3
151%
25.5
DK
Novo Nordisk A/S
CSE:NOVO B
20.2
84%
0.2
US
Johnson & Johnson
NYSE:JNJ
11.6
14%
0.8
US
Merck & Co Inc
NYSE:MRK
10.5
331%
0
CH
Roche Holding AG
SIX:ROG
9.8
23%
0.4
UK
AstraZeneca PLC
LSE:AZN
169.4
64%
2.7
CH
Novartis AG
SIX:NOVN
9.4
8%
1.2
US
Pfizer Inc
NYSE:PFE
10.6
31%
0.3
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
VN
D
Domesco Medical Import Export Joint Stock Corp
VN:DMC
Average EV/EBIT: 1 811.1
9.7
N/A N/A
JP
N
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Negative Multiple: -5 046 864.6 N/A N/A
US
Eli Lilly and Co
NYSE:LLY
54.1
211%
0.3
UK
Dechra Pharmaceuticals PLC
LSE:DPH
17 702.3
675%
26.2
DK
Novo Nordisk A/S
CSE:NOVO B
23
83%
0.3
US
Johnson & Johnson
NYSE:JNJ
15.1
28%
0.5
US
Merck & Co Inc
NYSE:MRK
12.5
675%
0
CH
Roche Holding AG
SIX:ROG
11.6
28%
0.4
UK
AstraZeneca PLC
LSE:AZN
253.9
131%
1.9
CH
Novartis AG
SIX:NOVN
13.1
58%
0.2
US
Pfizer Inc
NYSE:PFE
16
68%
0.2

See Also

Discover More
Back to Top